Tenet Healthcare

THC · NYSE

$272.32+$5.93 (+2.23%)TodayMarket closed ·
Prev close $266.39

About THC

Tenet Healthcare Corp. engages in the provision of healthcare services. The company is headquartered in Dallas, Texas and currently employs 77,000 full-time employees. The firm's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment consists of its acute care and specialty hospitals, imaging centers, ancillary outpatient facilities, micro-hospitals and physician practices. The firm's subsidiaries operate approximately 50 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 132 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency department and micro hospitals. The company also provides revenue cycle management and value based care services. Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 533 ambulatory surgery centers, and 26 surgical hospitals in 37 states. The company also operates a Global Business Center in the Philippines.

Employees
77,000
Headquarters
Dallas, Texas
Listed
May 22, 1981
Sector
Health Care
Industry
Health Care Providers & Services

THC key statistics

Market cap
21.45B
Price-earnings ratio
10.28
Dividend yield
—
Average volume
591.50K
Volume
462.15K
Open price
$267.99
High today
$272.81
Low today
$267.76
52 Week high
$283.05
52 Week low
$157.58

Tenet Healthcare (THC) at a glance

Tenet Healthcare (THC) last traded at $272.32, with a market cap of 21.45B and a price-to-earnings ratio of 10.28.

Today the stock has traded between $267.76 and $272.81. The current price is 1.7% above the day's low and 0.2% below its high.

Volume so far is 462.15K shares, below the average of 591.50K shares a day.

Over the past year Tenet Healthcare has ranged from $157.58 to $283.05, and now sits 91% of the way up that range.

Tenet Healthcare met or beat analyst EPS estimates in 4 of the last 4 quarters. In Q2 FY26 it reported $6.12 per share against an estimate of $4.26.

The average analyst price target is $289.13, 6.2% above the current price, from 17 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

88%of 17 analyst ratings say Buy
  • Buy88.2%
  • Hold11.8%
  • Sell0.0%
Price target · 24 analystsAvg $289.13
Low
$262.60
Now
$272.32
High
$324.45

THC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 4 quarters, by 20.9% on average.

  1. Q3 FY25: reported $3.70 per share against an estimate of $3.34
  2. Q4 FY25: reported $4.70 per share against an estimate of $4.09
  3. Q1 FY26: reported $4.82 per share against an estimate of $4.22
  4. Q2 FY26: reported $6.12 per share against an estimate of $4.26

THC news

  • FTC Issues Letters Warning Hospitals Against Deceptive Pricing Practices

  • Press releaseBusiness Wire

    Tenet to Report Its Third Quarter 2026 Results on October 29

  • Piero Cingari

    Junk Bond Yields Are Back Above 15%: 10 Stocks In The Pressure Zone

  • Press releaseBusiness Wire

    Tenet Announces Upsizing and Pricing of Its $2.0 Billion Private Offering of Senior Notes

  • Press releaseBusiness Wire

    Tenet Announces Private Offering of Senior Notes to Refinance $1.5 Billion in Outstanding Notes

  • Press releaseBusiness Wire

    Tenet to Participate in the Wells Fargo Healthcare Conference

  • 10 Health Care Stocks Whale Activity In Today’s Session

  • Vandana Singh

    Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade

Similar companies

Companies in the same industry as Tenet Healthcare

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.